Key result
The prevalence of masked nocturnal hypertension was significantly higher in summer (45.6%) compared to spring (27.2%), autumn (28.8%), and winter (24.9%; all P<0.05).
Why the study?
Little was known about seasonal variation in nighttime blood pressure measured by a home device.
Does seasonal variation affect nighttime home blood pressure and the prevalence of masked nocturnal hypertension in outpatients with cardiovascular risks?
Cross-Sectional (n=2,544)
Yes
Does seasonal variation affect nighttime home blood pressure and the prevalence of masked nocturnal hypertension in outpatients with cardiovascular risks?
Absolute Event Rate: 45.6% vs 27.2%
p-value: p=<0.05
Nighttime home systolic blood pressure and the prevalence of masked nocturnal hypertension are significantly higher in summer compared to other seasons.
May warrant seasonal nocturnal BP monitoring in at-risk patients; leaves open causal mechanisms and outcome impact.
BACKGROUND: Little is known about seasonal variation in nighttime blood pressure (BP) measured by a home device. In this cross-sectional study, we sought to assess seasonal variation in nighttime home BP using data from the nationwide, practice-based Japan Morning Surge-Home BP (J-HOP) Nocturnal BP study. METHODS: In this study, 2,544 outpatients (mean age 63 years; hypertensives 92%) with cardiovascular risks underwent morning, evening, and nighttime home BP measurements (measured at 2:00, 3:00, and 4:00 am) using validated, automatic, and oscillometric home BP devices. RESULTS: Our analysis showed that nighttime home systolic BP (SBP) was higher in summer than in other seasons (summer, 123.3 ± 14.6 mmHg vs. spring, 120.7 ± 14.8 mmHg; autumn, 121.1 ± 14.8 mmHg; winter, 119.3 ± 14.0 mmHg; all P<0.05). Moreover, we assessed seasonal variation in the prevalence of elevated nighttime home SBP (≥120 mmHg) in patients with non-elevated daytime home SBP (average of morning and evening home SBP <135 mmHg; n = 1,565), i.e., masked nocturnal hypertension, which was highest in summer (summer, 45.6% vs. spring, 27.2%; autumn, 28.8%; winter, 24.9%; all P<0.05). Even in intensively controlled morning home SBP (<125 mmHg), the prevalence of masked nocturnal hypertension was higher in summer (summer, 27.4% vs. spring, 14.2%; autumn, 8.9%; winter, 9.0%; all P<0.05). The urine albumin-creatinine ratio in patients with masked nocturnal hypertension tended to be higher than that in patients with non-elevated both daytime and nighttime SBP throughout each season. CONCLUSIONS: The prevalence of masked nocturnal hypertension was higher in summer than other seasons and the difference proved to be clinically meaningful.
No takes yet. Share an insight, caveat, or question.
Narita et al. (2020) conducted a cross-sectional in Cardiovascular risks (92% hypertensive) (n=2,544). Summer season vs. Other seasons (spring, autumn, winter) was evaluated on Prevalence of masked nocturnal hypertension (p=<0.05). The prevalence of masked nocturnal hypertension was significantly higher in summer (45.6%) compared to spring (27.2%), autumn (28.8%), and winter (24.9%; all P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: